Abstract

With COVID-19 impacting the economic, social, and political aspects of the world, supply chains of companies are repurposing their products to aid in fighting the pandemic with certain enabling factors that allow companies to respond and transition from typical production to meeting the exceptional needs of the medical industry. We research the challenges to a company's supply chain while shifting to needed products. We examine how or if the companies are utilizing their current supply chain to create a new supply chain for scarce healthcare products. Additionally, the logistics of being able to distribute the new products to the public, in terms of abiding by safety and sanitation regulations were explored. Furthermore, we examine how these companies plan on changing their supply chain and factories back to their original products once business returns to stable and level conditions. Based on fact-finding, we were able to determine whether companies were successful in their mission to provide resources to the medical industry during this time of crisis, and why that is.